N-Glycolyl GM3 cancer vaccine

N/A

Report date: 2026/02/18 20:02:09

Base Information

Drug NameN-Glycolyl GM3 cancer vaccine
Drug Alias NameN-glycolyl therapeutic vaccineN-乙醇GM3癌症疫苗N-Glycolyl GM3/Vssp vaccineN-羟乙酰基GM3癌疫苗NGcGM3/VSSP vaccine +[8] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUveal melanomaUterine NeoplasmsCarcinoma, Non-Small-Cell Lung +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A

Develop Information

Active CompaniesCenter Of Molecular ImmunologyRecombio Sl
Inactive CompaniesCancer Research InstituteLudwig Institute For Cancer ResearchNational Cancer Institute
Active IndicationsBreast Neoplasms
Inactive IndicationsUveal melanomaUterine NeoplasmsCarcinoma, Non-Small-Cell Lung +[15] 

Other Information

ATC CodeN/A
Related LinksN/A